MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-17-2026
ClearPoint Neuro Market Cap 2011-2026 | CLPT
As of March 25, 2026 ClearPoint Neuro has a market cap of $ 272 M
Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]
Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.
This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.
Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.
Annual Market Cap ClearPoint Neuro
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 316 M | 466 M | 149 M | 217 M | 183 M | 366 M | 68.4 M | 30 M | 20.9 M | 7.38 M | 29.4 M | 1.78 B | 3.07 B | 2.71 B | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 3.07 B | 7.38 M | 672 M |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.
Market Cap of other stocks in the Medical devices industry
| Issuer | Market Cap | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Delcath Systems
DCTH
|
326 M | $ 9.25 | 3.01 % | $ 331 M |  USA |
 |
BioSig Technologies
BSGM
|
7.3 M | - | 37.08 % | $ 85.7 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
933 M | - | - | $ 1.77 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
2.82 B | - | - | $ 3.31 B | USA |
 |
Lianluo Smart Limited
LLIT
|
147 M | - | 24.59 % | $ 44.8 M |  China |
 |
Aziyo Biologics
AZYO
|
26.9 M | - | 1.37 % | $ 20.5 M | USA |
 |
Acutus Medical
AFIB
|
5.24 M | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
4.01 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
35 M | - | -5.86 % | $ 30.6 M | USA |
 |
Second Sight Medical Products
EYES
|
225 K | - | -0.97 % | $ 54.4 M | USA |
 |
Conformis
CFMS
|
12.6 M | - | - | $ 16.4 M | USA |
 |
Helius Medical Technologies
HSDT
|
3.54 M | $ 2.13 | 6.22 % | $ 1.29 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
1.88 B | $ 9.57 | 0.26 % | $ 737 M | USA |
 |
IRIDEX Corporation
IRIX
|
48.1 M | $ 1.34 | -1.11 % | $ 21.6 M | USA |
 |
IRadimed Corporation
IRMD
|
1.25 B | $ 102.27 | 1.29 % | $ 1.3 B | USA |
 |
Cardiovascular Systems
CSII
|
588 M | - | 0.15 % | $ 844 M | USA |
 |
Apollo Endosurgery
APEN
|
403 M | - | - | $ 475 M | USA |
 |
Inogen
INGN
|
160 M | $ 6.44 | 1.9 % | $ 171 M | USA |
 |
Avinger
AVGR
|
2.59 M | - | -20.74 % | $ 369 K | USA |
 |
CryoLife, Inc.
CRY
|
906 M | - | -4.14 % | $ 702 M | USA |
 |
LivaNova PLC
LIVN
|
3.81 B | $ 63.45 | 1.68 % | $ 3.46 B |  Britain |
 |
CHF Solutions, Inc.
CHFS
|
1.05 M | - | 1.15 % | $ 34.5 M | USA |
 |
LENSAR
LNSR
|
130 M | $ 5.65 | 1.62 % | $ 65.1 M | USA |
 |
CONMED Corporation
CNMD
|
1.32 B | $ 36.82 | 0.71 % | $ 1.14 B | USA |
 |
Soliton, Inc.
SOLY
|
229 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
7.99 M | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
339 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
NanoVibronix
NAOV
|
920 K | - | - | $ 1.08 M | USA |
 |
Electromed
ELMD
|
175 M | $ 24.9 | 0.81 % | $ 211 M | USA |
 |
Misonix, Inc.
MSON
|
185 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
677 M | - | - | $ 111 M |  Canada |
 |
Medtronic PLC
MDT
|
111 B | $ 87.85 | 1.47 % | $ 113 B | USA |
 |
MiMedx Group
MDXG
|
779 M | $ 4.13 | -0.12 % | $ 610 M | USA |
 |
Intersect ENT, Inc.
XENT
|
735 M | - | - | $ 955 M | USA |
 |
Cytosorbents Corporation
CTSO
|
54.4 M | $ 0.66 | -4.56 % | $ 35.9 M | USA |
 |
Aethlon Medical
AEMD
|
3.03 M | $ 2.4 | 11.11 % | $ 3.75 M | USA |
 |
BIOLASE
BIOL
|
192 K | - | -13.19 % | $ 166 K | USA |
 |
Orthofix Medical
OFIX
|
491 M | $ 11.86 | 1.19 % | $ 470 M |  Curacao |
 |
InspireMD
NSPR
|
115 M | $ 1.76 | -0.56 % | $ 113 M | Israel |
 |
AdaptHealth Corp.
AHCO
|
1.2 B | $ 11.38 | -0.87 % | $ 1.54 B | USA |
 |
Penumbra
PEN
|
13.2 B | $ 336.12 | 0.58 % | $ 13.1 B | USA |
 |
Myomo
MYO
|
33.9 M | $ 0.7 | 0.22 % | $ 29.3 M | USA |
 |
Insulet Corporation
PODD
|
18.1 B | $ 220.23 | -2.34 % | $ 15.5 B | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
258 M | $ 2.31 | -3.96 % | $ 136 M | Israel |
 |
Invacare Corporation
IVC
|
24.1 M | - | - | $ 24.7 M | USA |
 |
EDAP TMS S.A.
EDAP
|
60 M | $ 3.76 | -3.84 % | $ 140 M |  France |
 |
Profound Medical Corp.
PROF
|
230 M | $ 5.73 | 11.26 % | $ 180 M | Canada |
 |
OrthoPediatrics Corp.
KIDS
|
437 M | $ 16.37 | 2.89 % | $ 384 M | USA |
 |
Quanterix Corporation
QTRX
|
269 M | $ 3.97 | 3.93 % | $ 169 M | USA |
 |
Outset Medical
OM
|
52.5 K | $ 3.53 | - | $ 53.7 K | USA |